Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-23-001655
Filing Date
2023-08-21
Accepted
2023-08-21 13:35:50
Documents
76
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 AXIM BIOTECHNOLOGIES FORM 10-Q axim-20230630.htm   iXBRL 10-Q 1510617
2 CERTIFICATION axim_ex311.htm EX-31 18437
3 CERTIFICATION axim_ex312.htm EX-31 18480
4 CERTIFICATION axim_ex321.htm EX-32 7243
5 CERTIFICATION axim_ex322.htm EX-32 7236
11 IMAGE image_001.jpg GRAPHIC 5736
  Complete submission text file 0001096906-23-001655.txt   7348175

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axim-20230630_cal.xml EX-101.CAL 57354
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axim-20230630_def.xml EX-101.DEF 256163
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT axim-20230630_lab.xml EX-101.LAB 419104
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axim-20230630_pre.xml EX-101.PRE 363700
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axim-20230630.xsd EX-101.SCH 76147
70 EXTRACTED XBRL INSTANCE DOCUMENT axim-20230630_htm.xml XML 1008641
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

EIN.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54296 | Film No.: 231188512
SIC: 2834 Pharmaceutical Preparations